Medtronic and WL Gore end litigation
This article was originally published in Clinica
Medtronic has settled a patent litigation case that it brought against WL Gore & Associates in 2006. Specific details of the agreement are confidential but Medtronic did say that it expects to recognise a one-time gain in its second fiscal quarter, ending October 30, 2009. The litigation had centred on Medtronic’s Jervis patents family, which cover the use of stress to restrain self-expanding medical devices made of Nitinol, including the firm’s transcatheter coronary heart valve products. The trial also covered the Wiktor stent patents.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals